We are live on
!
Find out more
Tudor Investment Corp Portfolio holdings
AUM
$53.9B
1-Year Est. Return
29.12%
This Fund
S&P 500
This Quarter
Est. Return
-3.9%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$30.1B
AUM Growth
+$3.82B
(+15%)
Cap. Flow
+$6.13B
Cap. Flow
% of AUM
20.35%
Top 10 Holdings %
Top 10 Hldgs %
39.75%
Holding
3,818
New
874
Increased
1,161
Reduced
890
Closed
844
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
CRISPR Therapeutics
CRSP
$5.22B
| $1.65M | 0.01% |
48,600
+43,200
| +800% | +$1.83M |
|
1477
American Water Works
AWK
$27.1B
| $1.65M | 0.01% |
+11,203
| New | +$1.48M |
|
|
FITB
1478
Fifth Third Bancorp
FITB
$52.5B
| $1.64M | 0.01% |
41,949
-17,857
| -30% | -$753K |
|
1479
Vanguard Morningstar Value ETF
VTV
$194B
| $1.64M | 0.01% |
+9,515
| New | +$1.66M |
|
1480
PUT
NRG Energy
NRG
$25.2B
| $1.64M | 0.01% |
17,200
+300
| +2% | +$30.3K |
|
1481
CALL
Idexx Laboratories
IDXX
$44.7B
| $1.64M | 0.01% |
3,900
-1,300
| -25% | -$564K |
|
1482
CALL
Futu Holdings
FUTU
$14.7B
| $1.64M | 0.01% |
16,000
-12,100
| -43% | -$1.24M |
|
1483
Park National Corp
PRK
$3.75B
| $1.63M | 0.01% |
+10,788
| New | +$1.77M |
|
1484
CALL
Mobileye
MBLY
$7.57B
| $1.63M | 0.01% |
113,200
+51,400
| +83% | +$840K |
|
1485
CALL
PennyMac Financial
PFSI
$4.13B
| $1.62M | 0.01% |
16,200
-13,900
| -46% | -$1.43M |
|
1486
Medtronic
MDT
$116B
| $1.62M | 0.01% |
18,037
-91,888
| -84% | -$8.22M |
|
1487
PUT
Southern Company
SO
$107B
| $1.62M | 0.01% |
17,600
-29,300
| -62% | -$2.54M |
|
1488
Immunocore
IMCR
$1.74B
| $1.62M | 0.01% |
+54,493
| New | +$1.63M |
|
1489
Arcutis Biotherapeutics
ARQT
$3.25B
| $1.62M | 0.01% |
103,373
+39,039
| +61% | +$550K |
|
1490
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
| $1.61M | 0.01% |
22,800
+8,700
| +62% | +$585K |
|
1491
PUT
CVS Health
CVS
$121B
| $1.61M | 0.01% |
23,700
-478,400
| -95% | -$28.6M |
|
1492
CALL
Axcelis
ACLS
$4.42B
| $1.6M | 0.01% |
32,300
-7,500
| -19% | -$474K |
|
1493
CALL
GoDaddy
GDDY
$12.7B
| $1.6M | 0.01% |
8,900
-19,400
| -69% | -$3.71M |
|
1494
PUT
Rocket Companies
RKT
$42.6B
| $1.6M | 0.01% |
132,800
-11,800
| -8% | -$152K |
|
|
SVC
1495
Service Properties Trust
SVC
$1.06B
| $1.6M | 0.01% |
122,590
+97,461
| +388% | +$1.32M |
|
1496
Idacorp
IDA
$8.16B
| $1.6M | 0.01% |
+13,748
| New | +$1.54M |
|
1497
CALL
Coherent
COHR
$64B
| $1.6M | 0.01% |
24,600
+10,900
| +80% | +$903K |
|
1498
PUT
Dave & Buster's
PLAY
$370M
| $1.59M | 0.01% |
90,700
+29,300
| +48% | +$694K |
|
|
SCHW
1499
PUT
Charles Schwab
SCHW
$190B
| $1.59M | 0.01% |
20,300
-9,500
| -32% | -$746K |
|
1500
PUT
Bloom Energy
BE
$69.6B
| $1.59M | 0.01% |
80,700
+10,500
| +15% | +$251K |
|
Similar funds
SCP
Tudor Investment Corp's Q1 2025 Portfolio in Review
As of Q1 2025, Tudor Investment Corp held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Tudor Investment Corp deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Tudor Investment Corp's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Tudor Investment Corp added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Tudor Investment Corp's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Tudor Investment Corp fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Tudor Investment Corp's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Tudor Investment Corp opened 874 new positions and closed 844 in Q1 2025.
- Tudor Investment Corp's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.